MDMA (XTC) Therapy Is a Healing Wonder Drug

As a psychotherapist in training, I gave many of my clients MDMA — now better known as XTC. This was back in 1984 — when it was still legal. In fact, my Master’s thesis was titled, “The Therapeutic Effects of MDMA on PTSD.” After working with about three-dozen clients suffering from PTSD, I concluded that a single session of MDMA assisted psychotherapy was as effective as about 60 to 75 weekly talk therapy sessions. Despite my own and other therapist’s promising research with this drug, in 1985 the federal government made MDMA a Schedule One controlled substance.

Since 1985, research with MDMA has been severely curtailed. In the meantime, it became known as a party drug, and a favorite at Raves. Yet, a few years ago, things began to change. That’s when two things happened. First, the U.S. government realized it was spending a lot of money on treating soldiers with PTSD, and getting really bad results. Second, the group known as MAPS (Multidisciplinary Association for Psychedelic Studies) started funding research into MDMA assisted psychotherapy for PTSD. What they found was what I found way back in 1984: MDMA works phenomenally well in helping people with PTSD.

According to Wikipedia, “In 2017, the treatment (MDMA assisted psychotherapy) was granted breakthrough therapy status by the FDA, a designation that indicates that there is preliminary evidence that an intervention…